Division of Pediatric Hematology-Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey.
Department of Pediatrics, King Hussein Cancer Center, Hematology/Oncology, Amman, Jordan.
Pediatr Blood Cancer. 2020 Aug;67(8):e28309. doi: 10.1002/pbc.28309. Epub 2020 May 30.
Germline biallelic mutations in one of the mismatch repair genes, mutS homolog 2, mutS homolog 6, mutL homolog 1, or postmeiotic segregation increased 2, result in one of the most aggressive cancer syndromes in humans termed as constitutional mismatch repair deficiency (CMMRD). Individuals with CMMRD are affected with multiple tumors arising from multiple organs during childhood, and these individuals rarely reach adulthood without specific interventions. The most common tumors observed are central nervous system, hematological, and gastrointestinal malignancies. The incidence of CMMRD is expected to be high in low-resource settings due to a high rate of consanguinity in these regions, and it is thought to be underrecognized and consequently underdiagnosed. This position paper is therefore important to provide a summary of the current situation, and to highlight the necessity of increasing awareness, diagnostic criteria, and surveillance to improve survival for patients and family members.
种系双等位基因突变一个错配修复基因,如 mutS 同源物 2、mutS 同源物 6、mutL 同源物 1 或减数后分离增加 2,会导致人类最具侵袭性的癌症综合征之一,即组成性错配修复缺陷(CMMRD)。CMMRD 患者在儿童期就会受到来自多个器官的多种肿瘤的影响,如果没有特定的干预措施,这些患者很少能成年。最常见的观察到的肿瘤是中枢神经系统、血液和胃肠道恶性肿瘤。由于这些地区存在很高的近亲结婚率,预计资源匮乏地区的 CMMRD 发病率会很高,而且由于认识不足,因此可能会漏诊。因此,本立场文件的重要性在于提供当前情况的总结,并强调提高认识、诊断标准和监测的必要性,以改善患者和家庭成员的生存率。